NCT07104032 · Interventional trial
IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Overall registry status Recruiting
Phase 3
Conditions Relapsed/Refractory Primary Central Nervous System Lymphoma
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory